Spots Global Cancer Trial Database for Research on the Role of SLC1A5 in the Development of Esophageal Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Research on the Role of SLC1A5 in the Development of Esophageal Cancer

Official Title: Research on the Role of the Amino Acid Transporter SLC1A5 in the Development of Esophageal Cancer

Study ID: NCT02633436

Conditions

Esophageal Cancer

Amino Acid Transport Disorder

Interventions

SLC1A5 expression

Study Description

Brief Summary: To explore the significance of Solute Carrier Family 1 Member 5 (SLC1A5) in the occurrence of esophageal cancer, by comparing the expression of SLC1A5 between esophageal cancer tissues and adjacent tissues.

Detailed Description: This will be an observational study. The investigators will aim to enroll 100 male and female adult patients (aged 18 years and over) of all ethnicities/races, who have been referred to the Fourth Affiliated Hospital of Guangxi Medical University for esophageal cancer. The investigators will be using a standardized data collection form. This is an observational study in which standard of care will be practiced and the patients are not placed at additional risk from participating in this study. However, as the investigators are collecting data prospectively, all participants will sign consent. An attempt will be made to see if there is a correlation between the expression of SLC1A5 with esophageal cancer.